RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response

The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed serious threats to global health and economy, thus calling for the development of safe and effective vaccines. The receptor-binding domain (RBD) in the spike protein o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Signal Transduct Target Ther
Autori principali: Liu, Zezhong, Xu, Wei, Xia, Shuai, Gu, Chenjian, Wang, Xinling, Wang, Qian, Zhou, Jie, Wu, Yanling, Cai, Xia, Qu, Di, Ying, Tianlei, Xie, Youhua, Lu, Lu, Yuan, Zhenghong, Jiang, Shibo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7691975/
https://ncbi.nlm.nih.gov/pubmed/33247109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-00402-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi